{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:33:31Z","timestamp":1777984411359,"version":"3.51.4"},"reference-count":22,"publisher":"Pacini Editore","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n0284","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T10:40:55Z","timestamp":1597056055000},"page":"198-203","source":"Crossref","is-referenced-by-count":5,"title":["Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia","Dati demografici e presenza di tremore, distonia cervicale e patologie delle corde vocali in un gruppo di pazienti con disfonia spasmodica"],"prefix":"10.14639","volume":"40","author":[{"given":"Selmin","family":"Karatayli Ozgursoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Rutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"20340","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"10.14639\/0392-100X-N0284_ref1","doi-asserted-by":"crossref","unstructured":"Tanner K. Epidemiologic advances in spasmodic dysphonia. SIG 3 Perspect Voice Voice Disord 2012;22:104-11. https:\/\/doi.org\/10.1044\/vvd22.3.104","DOI":"10.1044\/vvd22.3.104"},{"key":"10.14639\/0392-100X-N0284_ref2","doi-asserted-by":"crossref","unstructured":"Izdebski K, Dedo HH, Boles L. Spastic dysphonia: a patient profile of 200 cases. Am J Otolaryngol 1984;5:7-14. https:\/\/doi.org\/10.1016\/s0196-0709(84)80015-0","DOI":"10.1016\/S0196-0709(84)80015-0"},{"key":"10.14639\/0392-100X-N0284_ref3","doi-asserted-by":"crossref","unstructured":"Schweinfurth JM, Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope 2002;112:220-3. https:\/\/doi.org\/10.1097\/00005537-200202000-00004","DOI":"10.1097\/00005537-200202000-00004"},{"key":"10.14639\/0392-100X-N0284_ref4","doi-asserted-by":"crossref","unstructured":"Tanner K, Roy N, Merrill RM, et al. Case-control study of risk factors for spasmodic dysphonia: a comparison with other voice disorders. Laryngoscope 2012;122:1082-92. https:\/\/doi.org\/10.1002\/lary.22471","DOI":"10.1002\/lary.22471"},{"key":"10.14639\/0392-100X-N0284_ref5","doi-asserted-by":"crossref","unstructured":"de Gusmao CM, Fuchs T, Moses A, et al. Dystonia-causing mutations as a contribution to the etiology of spasmodic dysphonia. Otolaryngol Head Neck Surg 2016;155:624-8. https:\/\/doi.org\/10.1177\/0194599816648293","DOI":"10.1177\/0194599816648293"},{"key":"10.14639\/0392-100X-N0284_ref6","doi-asserted-by":"crossref","unstructured":"Jinnah HA, Berardelli A, Comella C, et al. The focal dystonias: current views and challenges for future research. Mov Disord 2013;28:926-43. https:\/\/doi.org\/10.1002\/mds.25567","DOI":"10.1002\/mds.25567"},{"key":"10.14639\/0392-100X-N0284_ref7","doi-asserted-by":"crossref","unstructured":"Ludlow CL, Adler CH, Berke GS, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 2008;139:495-505. https:\/\/doi.org\/10.1016\/j.otohns.2008.05.624","DOI":"10.1016\/j.otohns.2008.05.624"},{"key":"10.14639\/0392-100X-N0284_ref8","doi-asserted-by":"crossref","unstructured":"Hintze JM, Ludlow CL, Bansberg SF, et al. Spasmodic dysphonia: a review. Part 1: pathogenic factors. Otolaryngol Head Neck Surg 2017;157:551-7. https:\/\/doi.org\/10.1177\/0194599817728521","DOI":"10.1177\/0194599817728521"},{"key":"10.14639\/0392-100X-N0284_ref9","doi-asserted-by":"crossref","unstructured":"De Bodt M, Van den Steen L, Mertens F, et al. Characteristics of a dysphonic population referred for voice assessment and\/or voice therapy. Folia Phoniatr Logop 2015;67:178-86. https:\/\/doi.org\/10.1159\/000369339","DOI":"10.1159\/000369339"},{"key":"10.14639\/0392-100X-N0284_ref10","doi-asserted-by":"crossref","unstructured":"Mozzanica F, Ginocchio D, Barillari R, et al. Prevalence and voice characteristics of laryngeal pathology in an italian voice therapy-seeking population. J Voice 2016;30:774.e13-21. https:\/\/doi.org\/10.1016\/j.jvoice.2015.11.018","DOI":"10.1016\/j.jvoice.2015.11.018"},{"key":"10.14639\/0392-100X-N0284_ref11","doi-asserted-by":"crossref","unstructured":"Schaefer SD. Neuropathology of spasmodic dysphonia. Laryngoscope 1983;93:1183-204. https:\/\/doi.org\/10.1288\/00005537-198309000-00015","DOI":"10.1288\/00005537-198309000-00015"},{"key":"10.14639\/0392-100X-N0284_ref12","doi-asserted-by":"crossref","unstructured":"Childs L, Rickert S, Murry T, et al. Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients. Laryngoscope 2011;121:2195-8. https:\/\/doi.org\/10.1002\/lary.22168","DOI":"10.1002\/lary.22168"},{"key":"10.14639\/0392-100X-N0284_ref13","doi-asserted-by":"crossref","unstructured":"Tanner K, Roy N, Merrill RM, et al. Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response. Ann Otol Rhinol Laryngol 2011;120:465-73. https:\/\/doi.org\/10.1177\/000348941112000708","DOI":"10.1177\/000348941112000708"},{"key":"10.14639\/0392-100X-N0284_ref14","doi-asserted-by":"crossref","unstructured":"White LJ, Hapner ER, Klein AM, et al. Coprevalence of anxiety and depression with spasmodic dysphonia: a case-control study. J Voice 2012;26:667.e1-6. https:\/\/doi.org\/10.1016\/j.jvoice.2011.08.011","DOI":"10.1016\/j.jvoice.2011.08.011"},{"key":"10.14639\/0392-100X-N0284_ref15","doi-asserted-by":"crossref","unstructured":"Patel AB, Bansberg SF, Adler CH, et al. The Mayo Clinic Arizona spasmodic dysphonia experience: a demographic analysis of 718 patients. Ann Otol Rhinol Laryngol 2015;124:859-63. https:\/\/doi.org\/10.1177\/0003489415588557","DOI":"10.1177\/0003489415588557"},{"key":"10.14639\/0392-100X-N0284_ref16","doi-asserted-by":"crossref","unstructured":"Tisch SH, Brake HM, Law M, et al. Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients - an Australian experience. J Clin Neurosci 2003;10:434-8. https:\/\/doi.org\/10.1016\/s0967-5868(03)00020-1","DOI":"10.1016\/S0967-5868(03)00020-1"},{"key":"10.14639\/0392-100X-N0284_ref17","doi-asserted-by":"crossref","unstructured":"White LJ, Klein AM, Hapner ER, et al. Coprevalence of tremor with spasmodic dysphonia: a case-control study. Laryngoscope 2011;121:1752-5. https:\/\/doi.org\/10.1002\/lary.21872","DOI":"10.1002\/lary.21872"},{"key":"10.14639\/0392-100X-N0284_ref18","doi-asserted-by":"crossref","unstructured":"Adler CH, Edwards BW, Bansberg SF. Female predominance in spasmodic dysphonia. J Neurol Neurosurg Psychiatry 1997;63:688. https:\/\/doi.org\/10.1136\/jnnp.63.5.688","DOI":"10.1136\/jnnp.63.5.688"},{"key":"10.14639\/0392-100X-N0284_ref19","doi-asserted-by":"crossref","unstructured":"Creighton FX, Hapner E, Klein A, et al. Diagnostic delays in spasmodic dysphonia: a call for clinician education. J Voice 2015;29:592-4. https:\/\/doi.org\/10.1016\/j.jvoice.2013.10.022","DOI":"10.1016\/j.jvoice.2013.10.022"},{"key":"10.14639\/0392-100X-N0284_ref20","doi-asserted-by":"crossref","unstructured":"Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol 2010;17(Suppl 1):28-30. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03047.x","DOI":"10.1111\/j.1468-1331.2010.03047.x"},{"key":"10.14639\/0392-100X-N0284_ref21","doi-asserted-by":"crossref","unstructured":"Blitzer A, Brin MF, Fahn S, et al. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988;98:636-40. https:\/\/doi.org\/10.1288\/00005537-198806000-00012","DOI":"10.1288\/00005537-198806000-00012"},{"key":"10.14639\/0392-100X-N0284_ref22","doi-asserted-by":"crossref","unstructured":"Rincon F, Louis ED. Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management. Expert Opin Drug Saf 2005;4:899-913. https:\/\/doi.org\/10.1517\/14740338.4.5.899","DOI":"10.1517\/14740338.4.5.899"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:15:55Z","timestamp":1729667755000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n0284","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"article-number":"6"}}